Advisor Net Financial, Inc Ultragenyx Pharmaceutical Inc. Transaction History

Advisor Net Financial, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$36.08 - $45.83 $48,708 - $61,870	-1,350 Reduced 47.37%	1,500 $64,000
Q4 2018 Feb 08, 2019	BUY	$38.89 - $77.3 $25,278 - $50,245	650 Added 29.55%	2,850 $124,000
Q4 2017 Feb 27, 2018	BUY	$43.54 - $57.32 $95,788 - $126,104	2,200	2,200 $102,000

329

85.9M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.